Boundless Bio Inc
NASDAQ:BOLD

  • LAST PRICE
    2.5700
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.5300/ 1
  • Ask / Lots
    2.6800/ 3
  • Open / Previous Close
    --- / 2.5700
  • Day Range
    ---
  • 52 Week Range
    2.5000
    15.2400
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 7, 2024

      Show headlines and story abstract

    • 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: BOLD

      renee@thrustsc.com
      BOUNDLESS BIO, INC. Condensed Financial Information (Unaudited) Condensed Statements of Three Months Ended Nine Months Ended Operations Data: September 30, September 30, ---------------------------- --------------------------- (In thousands, except per share amounts) 2024 2023 2024 2023 ----------- ----------- ------------ --------- Operating expenses: Research and development $ 14,089 $ 11,645 $ 41,953 $ 32,223 General and administrative 4,626 3,308 13,036 8,777 ------- ------- -------- -------- Total operating expenses 18,715 14,953 54,989 41,000 ------- ------- -------- -------- Loss from operations (18,715 ) (14,953) (54,989 ) (41,000) Other income, net: Interest income 2,174 1,748 5,977 3,662 Other income, net 32 32 97 48 ------- ------- -------- -------- Total other income, net 2,206 1,780 6,074 3,710 ------- ------- -------- -------- Net loss $ (16,509 ) $ (13,173) $ (48,915 )$ (37,290) ======= ======= ======== ======== Net loss per share, basic and diluted $ (0.74 ) $ (10.71) $ (3.22 )$ (30.89) ======= ======= ======== ======== Weighted-average shares used in calculation 22,254 1,230 15,204 1,207 ======= ======= ======== ======== Condensed Balance September Sheet Data: 30, December 31, (In thousands) 2024 2023 ------------ --------- Cash, cash equivalents, and short-term investments $ 167,135 $ 120,752 Total assets $ 175,093 $ 129,894 Total liabilities $ 10,010 $ 9,359 Convertible preferred stock $ - $ 247,617 Accumulated deficit $ (185,024 )$(136,109) Total stockholders' equity (deficit) $ 165,083 $(127,082) Working capital (1) $ 160,439 $ 114,845 __________ (1) We define working capital as current assets less current liabilities.

    • 4:01PM ET on Thursday Nov 07, 2024 by Dow Jones
      Companies Mentioned: BOLD

      renee@thrustsc.com
      BOUNDLESS BIO, INC. Condensed Financial Information (Unaudited) Condensed Statements of Three Months Ended Nine Months Ended Operations Data: September 30, September 30, ---------------------------- --------------------------- (In thousands, except per share amounts) 2024 2023 2024 2023 ----------- ----------- ------------ --------- Operating expenses: Research and development $ 14,089 $ 11,645 $ 41,953 $ 32,223 General and administrative 4,626 3,308 13,036 8,777 ------- ------- -------- -------- Total operating expenses 18,715 14,953 54,989 41,000 ------- ------- -------- -------- Loss from operations (18,715 ) (14,953) (54,989 ) (41,000) Other income, net: Interest income 2,174 1,748 5,977 3,662 Other income, net 32 32 97 48 ------- ------- -------- -------- Total other income, net 2,206 1,780 6,074 3,710 ------- ------- -------- -------- Net loss $ (16,509 ) $ (13,173) $ (48,915 )$ (37,290) ======= ======= ======== ======== Net loss per share, basic and diluted $ (0.74 ) $ (10.71) $ (3.22 )$ (30.89) ======= ======= ======== ======== Weighted-average shares used in calculation 22,254 1,230 15,204 1,207 ======= ======= ======== ======== Condensed Balance September Sheet Data: 30, December 31, (In thousands) 2024 2023 ------------ --------- Cash, cash equivalents, and short-term investments $ 167,135 $ 120,752 Total assets $ 175,093 $ 129,894 Total liabilities $ 10,010 $ 9,359 Convertible preferred stock $ - $ 247,617 Accumulated deficit $ (185,024 )$(136,109) Total stockholders' equity (deficit) $ 165,083 $(127,082) Working capital (1) $ 160,439 $ 114,845 __________ (1) We define working capital as current assets less current liabilities.

  • Nov 5, 2024

Peers Headlines